Phosphodiesterase 4D5 Expression in Human Airway Smooth Muscle Cells is Controlled by Cyclic AMP

2003 ◽  
Vol 104 (s49) ◽  
pp. 60P-60P
Author(s):  
I R Le Jeune ◽  
M D Houslay ◽  
I P Hall
2002 ◽  
Vol 277 (39) ◽  
pp. 35980-35989 ◽  
Author(s):  
Ivan R. Le Jeune ◽  
Malcolm Shepherd ◽  
Gino Van Heeke ◽  
Miles D. Houslay ◽  
Ian P. Hall

1993 ◽  
Vol 84 (2) ◽  
pp. 151-157 ◽  
Author(s):  
Ian P. Hall ◽  
Keri Daykin ◽  
Sophie Widdop

1. The mechanisms underlying control of cyclic AMP responses to isoprenaline were studied in primary cultures of human airway smooth muscle cells. In these cells, isoprenaline induced concentration-related cyclic AMP formation via β2-adrenoceptor stimulation. 2. Prior incubation of cells with varying concentrations of isoprenaline (1–16 h), forskolin, prostaglandin E2 or a stable analogue of cyclic AMP all produced concentration-related desensitization of cyclic AMP responses to subsequent challenge with isoprenaline (maximum reduction with 1 μmol/l isoprenaline, 85% after 16 h). The desensitization induced over 2 h (44%) by a concentration of prostaglandin E2 which gave a similar rise in cyclic AMP levels to 1 μmol/l isoprenaline was significantly less (P < 0.05) than the desensitization (62%) induced over 2 h by 1 μmol/l isoprenaline itself. 3. Isoprenaline-induced desensitization of β2-adrenoceptor-induced cyclic AMP formation was insensitive to prior exposure of cells to dexamethasone. 4. These findings suggest that isoprenaline-induced desensitization of β2-adrenoceptor-induced cyclic AMP formation in primary cultures of human airway smooth muscle cells is mediated through both a cyclic AMP-dependent and probably an additional cyclic AMP-independent pathway, and that these pathways are insensitive to inhibition by glucocorticoids.


2003 ◽  
Vol 284 (6) ◽  
pp. L1020-L1026 ◽  
Author(s):  
Stephen M. Carlin ◽  
Michael Roth ◽  
Judith L. Black

We investigated the chemotactic action of PDGF and urokinase on human airway smooth muscle (HASM) cells in culture. Cells were put in collagen-coated transwells with 8-μm perforations, incubated for 4 h with test compounds, then fixed, stained, and counted as migrated nuclei by microscopy. Cells from all culture conditions showed some basal migration (migration in the absence of stimuli during the assay), but cells preincubated for 24 h in 10% FBS or 20 ng/ml PDGF showed higher basal migration than cells quiesced in 1% FBS. PDGFBB, PDGFAA, and PDGFABwere all chemotactic when added during the assay. PDGF chemotaxis was blocked by the phosphatidyl 3′-kinase inhibitor LY-294002, the MEK inhibitor U-0126, PGE2, formoterol, pertussis toxin, and the Rho kinase inhibitor Y-27632. Urokinase alone had no stimulatory effect on migration of quiescent cells but caused a dose-dependent potentiation of chemotaxis toward PDGF. Urokinase also potentiated the elevated basal migration of cells pretreated in 10% FBS or PDGF. This potentiating effect of urokinase appears to be novel. We conclude that PDGF and similar cytokines may be important factors in airway remodeling by redistribution of smooth muscle cells during inflammation and that urokinase may be important in potentiating the response.


Sign in / Sign up

Export Citation Format

Share Document